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Abstract
Changes in sodium channel activity and neuronal hyperexcitability contribute to neuropathic pain,
a major clinical problem. There is strong evidence that the re-expression of the embryonic voltage-
gated sodium channel subunit Nav1.3 underlies neuronal hyperexcitability and neuropathic pain.
Here we show that acute and inflammatory pain behaviour is unchanged in global Nav1.3 mutant
mice. Surprisingly, neuropathic pain also developed normally in the Nav1.3 mutant mouse. To rule
out any genetic compensation mechanisms that may have masked the phenotype, we investigated
neuropathic pain in two conditional Nav1.3 mutant mouse lines. We used Nav1.8-Cre mice to
delete Nav1.3 in nociceptors at E14 and NFH-Cre mice to delete Nav1.3 throughout the nervous
system postnatally. Again normal levels of neuropathic pain developed after nerve injury in both
lines. Furthermore, ectopic discharges from damaged nerves were unaffected by the absence of
Nav1.3 in global knock-out mice. Our data demonstrate that Nav1.3 is neither necessary nor
sufficient for the development of nerve-injury related pain.
Background
Neuropathic pain is an important and unmet clinical
problem. There is a lack of effective drugs for its treatment
and in some cases the pain is resistant to the strongest
analgesics [1]. Hyperexcitability of damaged sensory neu-
rons, as a result of injury to and/or demyelination of their
peripheral axons, is thought to initiate the processes that
lead to most neuropathic pain [2,3]. Hyper-excitable neu-
rons can fire spontaneously, causing spontaneous pain, or
become hypersensitive to otherwise innocuous mechani-
cal and thermal stimuli giving rise to allodynia (noxious
responses to innocuous stimuli) and hyperalgesia
(increased perception of noxious stimuli) [2,3].
Injured sensory neurons undergo major changes in gene
expression that have been catalogued in microarray stud-
ies [4-6]. Altered expression of voltage-gated sodium
channels (VGSC), which underlie the electrical excitabil-
ity of nerve and muscle, has been extensively studied [7].
Ectopic activity in damaged neurons [8] and neuropathic
pain behavior [9] have been shown to be sensitive to the
VGSC blocker, Tetrodotoxin (TTX). Sensory neurons
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express multiple subtypes of TTX-sensitive and TTX-resist-
ant VGSCs [10]. The expression of Nav1.1, Nav1.2, Nav1.6,
Nav1.7, Nav1.8 and Nav1.9 subunits is down-regulated,
whereas only Nav1.3, a TTX-sensitive channel, is up-regu-
lated following peripheral nerve injury [10-16]. Nav1.3 is
expressed throughout the embryonic nervous system but
is down-regulated in adults [11,17]. Coinciding with the
re-expression of the Nav1.3 channel in injured neurons,
the voltage-gated sodium currents recover from inactiva-
tion fourfold faster than that in uninjured neurons [13].
This is thought to be a direct result of expression of Nav1.3
as it possesses similar inactivation kinetics when
expressed in cell lines [18]. Rapid recovery from inactiva-
tion could allow damaged nerves to fire at higher frequen-
cies than otherwise [13]. Therefore, it is hypothesized that
mis-expression of VGSCs and in particular the re-expres-
sion of Nav1.3 is an important factor contributing to the
hyperexcitability of injured neurons. Several pieces of evi-
dence support this hypothesis. Firstly, the ectopic activity
[8] and mechanical allodynia [9] associated with nerve
injury has been shown to be sensitive to TTX. Secondly,
Glial-derived neurotrophic factor (GDNF), which reverses
neuropathic pain behaviour, reverses Nav1.3 up-regula-
tion [19]. Finally, intrathecal administration of antisense
oligonucleotides directed against Nav1.3 mRNA reverses
neuropathic pain behaviour and restores the inactivation
kinetics of VGSC to that of uninjured neurons [20,21].
Taken together, these data suggest that Nav1.3 is a good
target for analgesic drug development [22]. However, a
recent study using a different antisense oligonucleotide
sequence directed against Nav1.3 failed to reverse neuro-
pathic pain behaviour [23].
Here we describe the generation of 3 Nav1.3 mutant
mouse lines to test the hypothesis that Nav1.3 has a caus-
ative role in nerve-injury-induced chronic pain [22]. Our
data shows, contrary to expectation, that Nav1.3 is neither
responsible nor necessary for ectopic activity and neuro-
pathic pain behaviour.
Results and Discussion
We used a genetic approach to investigate the contribu-
tion of Nav1.3 to setting pain thresholds, to the hyperex-
citability of injured neurons and neuropathic pain
behaviour in mice. We generated a floxed Nav1.3 mouse,
(Figure 1a–b) and used a deletor mouse strain expressing
Cre recombinase before E4 [24] to generate a conven-
tional global null mutant (Nav1.3 KO), (Figure 1c). To
confirm deletion of Nav1.3 we used RT-PCR to amplify
sequences between exons 2 and 10, figure 1d. Sequencing
of the PCR product from the Nav1.3 KO brain confirmed
the deletion of 221 bp representing the floxed exons 4 and
5, (Figure 1e). Sequencing of the PCR product from WT
brain revealed that most of the Nav1.3 mRNA carries the
adult exon five (about 80%), (Figure 1f).
Nav1.3 KO mice were healthy, fertile, grew as well as their
littermate controls (WT), (figure 2a), and performed
equally well on the rotarod, (figure 2b). Peak sodium cur-
rents in cultured sensory neurons were unaffected by
Nav1.3 gene deletion, (figure 2c).
We next examined acute pain thresholds in adult Nav1.3
KO animals. Thermal and mechanical thresholds are nor-
mal, (Figure 3a–d), indicating that Nav1.3 does not play a
role in setting pain thresholds in the undamaged nervous
system. Although it has been reported that Nav1.3 is up-
regulated in an inflammatory pain model [25], we found
that pain behaviour evoked by injection of formalin and
CFA into the hindpaw was the same in both Nav1.3 KO
and WT mice, (Figure 3e–g). This indicates that Nav1.3
does not play a role in inflammatory pain, in marked con-
trast to Nav1.7 KO mouse, which shows an almost com-
plete loss of inflammatory pain [26].
Nav1.3 and neuronal excitability
Does Nav1.3 play a role in neuronal hyperexcitabtility fol-
lowing nerve injury? Voltage-gated sodium currents in
injured neurons recover from inactivation fourfold faster
than that in naive neurons possibly as a result of up-regu-
lation of Nav1.3 [13,18]. Rapid recovery from inactivation
could allow damaged nerves to fire at higher frequencies
[11]. The ectopic activity associated with nerve injury,
which has been shown to be sensitive to TTX, is an impor-
tant trigger for neuropathic pain behaviour [8,27]. We
therefore measured ectopic discharges from teased fibres
of the damaged (L5) and spared (L4) 24 hours after sur-
gery in Nav1.3 KO and WT mice. L5 spinal nerve ligation
induces spontaneous activity in L4 as well as L5 myeli-
nated fibres, though the percentage of active neurons in
mouse appears to be less than that in rat [19]. The percent-
age of spontaneously active fibres from L5 DRG was three
fold higher than that from L4 DRG, (Figure 4b), which is
similar to earlier results in rats [19]. Importantly, the per-
centage of spontaneously active fibres was not different
between the Nav1.3 KO and WT, (Figure 4a). In addition,
other characteristics of the spontaneous activity such as
the number of bursts per minute, (Figure 4b), mean
number of spikes per burst, (Figure 4c), and the mean
burst length, (Figure 4c), were also not different. These
findings suggest that Nav1.3 does not play an essential
role in the ectopic hyperexcitability of damaged nerves.
Nav1.3 and neuropathic pain
GDNF reverses the up-regulation of Nav1.3 and neuro-
pathic pain behaviour [19], and antisense oligonucle-
otides against Nav1.3 sequence reverse neuropathic pain
behaviour [20,21]. Therefore, we measured mechanical
pain thresholds in Nav1.3 KO mice following tight liga-
tion of spinal nerve L5 (Chung model). Surprisingly, a
robust mechanical allodynia developed in both Nav1.3
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Generation of floxed and global Nav1.3 KO miceFigure 1
Generation of floxed and global Nav1.3 KO mice. (A) Schematic representation of Nav1.3 WT locus, targeting con-
struct, floxed allele and global KO allele. (B) Southern blotting of tail DNA with BamHI and 5' probe confirms correct insertion 
of the targeting construct and (C) deletion of floxed exons in global KO mice. (D) RT-PCR on 1 μg of total RNA from P0 Brain 
confirms complete deletion of exon 4&5 in global KO mice. (E) Alignment of sequence of KO (red) and WT (black) RT-PCR 
bands shows the deleted 221 bp. Splicing of exon 3 (red) and 6 (black) causes frame shift and a truncated protein (asterisk = 
stop codon). (F) Sequencing of the WT RT-PCR shows that the P0 brain contains the two forms of exon five. The adult form 
is about 4 times more than the neonatal form.
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KO and WT mice from day 3 post-surgery and persisted
throughout the experiment, (Figure 5a). Sodium currents
in cultured sensory neurons were unaffected by Nav1.3
gene deletion, (Figure 2c), suggesting a lack of compensa-
tory changes.
In order to rule out the possibility that genetic compensa-
tion had confounded the behavioural phenotype in the
Nav1.3 KO, we generated two conditional knockout
strains; we mated the floxed Nav1.3 mouse to the Nav1.8
Cre line [28] to delete Nav1.3 in nociceptors from E14,
and with the NFH-Cre mouse line [29] to delete Nav1.3 in
CNS and PNS from the 10th postnatal week. Mice in both
conditional knockout strains developed a profound
mechanical allodynia soon after surgery that was not dif-
ferent from that of littermate controls (floxed Nav1.3),
(Figure 5b and 5c), confirming our results using the con-
ventional global KO. We conclude that Nav1.3 does not
play a critical role in either the induction or maintenance
of neuropathic pain behaviour.
Our results can be explained as follows; the level of Nav1.3
expression in sensory neurons following injury is esti-
mated to increase by about 1.4–2 fold [5,15] which is still
very small considering the almost undetectable level of
Nav1.3 in adult sensory neurons. Thus the increase in
sodium currents due to the up-regulated Nav1.3 is
unlikely to be significant in comparison to the total
sodium current before injury. The reported fast kinetics of
the Nav1.3 current [18] suggests that the qualitative aspect
of the Nav1.3 up-regulation may be more important than
the quantitative one. Our results using the global Nav1.3
KO rule out this in stimulus-evoked neuropathic pain.
This is because Nav1.3 is deleted in all cell types regardless
of the extent to which they up-regulate Nav1.3, the type of
cells involved (small vs large sensory neurons and DRG vs
central neurons) and the sub-cellular localization of
Nav1.3 (somata vs terminals). Furthermore, although
some antisense studies suggest a causal role for Nav1.3 in
neuropathic pain [20,21], the specificity of the oligonu-
cleotides used is not absolute (of 21 bases 15 are identical
to Nav1.1, 17 to Nav1.2 and 14 to Nav1.6), and another
antisense study using different specific oligonucleotides
has failed to confirm these findings [23].
Sodium channels and neuropathic pain
The role of VGSCs in the pathogenesis of neuropathic
pain has recently come under increasing scrutiny.
Changes in neuronal hyperexcitability have not been
found to correlate with changes in sodium currents [30].
Nevertheless, the effectiveness of non-subtype selective
sodium channel blockers in treating neuropathic pain [1]
has stimulated the search for a specific underlying sodium
channel subunit against which, more potent and selective
analgesics can be developed. It seems likely, however, that
no single sodium channel is specifically associated with
neuronal hyperexcitability in damaged nerves, but that
aberrant expression of high densities of sodium channels
Global Nav1.3 KO mice develop normallyFigure 2
Global Nav1.3 KO mice develop normally. (A) Weight (males P = 0.28 and females P = 0.80) and (B) performance on the 
rotarod (P = 0.21) were not different between the Nav1.3 KO (black) and WT (white). (C) Peak current density (nA/pF) of 
TTX-s current for small neurons (<25 μm) in WT = 0.097 ± 0.023 vs. KO = 0.156 ± 0.033 (n = 9 and 11, respectively; P = 
0.16). TTX-r current (corresponding to Nav1.8) in WT = 0.065 ± 0.028 vs. KO = 0.115 ± 0.029 (P = 0.24). Peak current density 
of TTX-s current in medium neurons (>27 μm) in WT = 0.179 ± 0.69 vs. KO = 0.223 ± 0.055 (n = 5 and 6, respectively; P = 
0.63). TTX-r current in WT = 0.071 ± 0.034 vs. KO = 0.118 ± 0.054 (P = 0.49).
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at the damaged terminals of sensory neurons may result in
hyperexcitability [31]. In support of this we have recently
shown that neither Nav1.7 nor 1.8 is necessary for the
development of neuropathic pain [32]. Nav1.9 null
mutants have also been shown to develop neuropathic
pain normally [33]. By contrast, it is clear that Nav1.7
plays a major role in the development of inflammatory
pain and subtype specific channel blockers directed
against this channel may be desirable for the treatment of
inflammatory pain.
The role in neuropathic pain pathogenesis of the other
major VGSC subunits in DRG, Nav1.1, Nav1.2 and Nav1.6,
remains to be investigated. Because of their relative abun-
dance it is expected that deletion of these subunits may
not have a specific effect on neuropathic pain. Almost cer-
tainly the usefulness of Nav1.1, Nav1.2 or Nav1.6 blockers
in treating neuropathic pain will be greatly undermined
by their broad expression in the CNS [10].
Conclusion
Neuropathic pain may be more amenable to local treat-
ment with broad-spectrum sodium channel blockers,
rather than those targeted at a specific sodium channel
subunit such as Nav1.3.
Acute and inflammatory pain behaviour in Nav1.3 KO is normalFigure 3
Acute and inflammatory pain behaviour in Nav1.3 KO is normal. Thermal threshold in the Hargreave's (A, WT 7.83 
± 0.7 sec, n = 8; KO 7.82 ± 0.6 sec, n = 11; P = 0.9) and hotplate apparatus (B, at 50°C WT 41.3 ± 7.3, n = 13; KO 44.2 ± 6.5, 
n = 13; P = 0.7. at 55°C WT 16.6 ± 2.4; KO 14.3 ± 1.8; P = 0.1) were similar. Mechanical threshold to range of von Frey hairs 
applied to hindpaw (C) and plunt force applied to tail (D, WT 157 ± 22.7 g, n = 13; KO 145 ± 18.2, n = 13; P = 0.4) were not 
different. Both phase of the formalin pain response were not different (E, phase 1 WT 86.1 ± 12.9 sec, n = 8; KO 78.4 ± 9.2, n 
= 8; P = 0.6. Phase 2 WT 210 ± 38.3 sec; KO 227.4 ± 24.2; P = 0.7). Injection of CFA in hindpaw elicited thermal (F) and 
mechanical hyperalgesia 2 days post injection (G, WT 0.3 ± 0.08 gram, n = 6; KO 0.23 ± 0.05, n = 6; P = 0.5) to the same level 
in both mice groups.
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Methods
Generation of floxed Nav1.3 mouse
An RCPI-22 129S6/SvEvTac mouse BAC library was
screened using a probe representing exons 4–12. DNA
from positive BAC clones was prepared and subcloned
into pBluescript (BS-SKII-). Three subclones were
obtained that covered Nav1.3 sequences from exon 2–8.
The construct was prepared in three steps. Firstly, the 3'
arm, Neomycin cassette and one LoxP site were cloned
together as follows; two oligonucleotides were cloned in
BS-SKII- to form new cloning sites. One LoxP site was
cloned as an EcoRI-PstI fragment from PLneo vector [26].
The 3' arm was cloned as ClaI-BamHI 7 Kb fragment. Neo-
mycin cassette was cloned as BamHI-SalL fragment from
Py6.0 plasmid [26]. Secondly, the 5' arm, one LoxP and
the floxed exons were cloned together as follows; 7 kb
fragment ClaI-SacI was cloned in BS-SKII-. A LoxP site was
inserted into the BsmBI site of the genomic fragment
through blunt ligation. Finally, the two halves above were
cloned into a vector containing the Thymidine-Kinase
(TK) cassette as follows; the 3' side was prepared as Not-
ClaI fragment, the 5' side was prepared as ClaI-SacII frag-
ment and the TK containing vector was prepared as Not-
SacII fragment. All were ligated together in the same tube.
Positive clones were confirmed by restriction digests and
sequencing. Blastocyst injection was performed by Mon-
ica Mendelson (Colombia University). Chimeras were
crossed to C57BL/6 and germ line transmission tested
using Southern blotting of tail DNA derived from F1 off-
spring. F1 heterozygotes were crossed to FLPe deletor ani-
mals [34] to excise the positive selection marker.
Behavioural analysis
All tests were approved by the United Kingdom Home
Office Animals (Scientific Procedures) Act 1986. They
were performed in a Home Office designated room at 22
± 2°C. Tests were carried out as previously descried [28].
Formalin test: 20 μl of 5% formalin (37% formaldehyde
(BDH) diluted with 0.9% saline (Sigma)) was injected
subcutaneously into the plantar aspect of a hind-paw
using a Hamilton syringe and 27 g needle and animals
were placed in a 20 × 20 × 20 cm Plexiform chamber. The
amount of time spent licking or biting the injected paw
was then recorded in 5 minute periods over the next hour.
Animals were habituated to the test environment for at
least 1 hr before experiments were started. Activity during
the first phase, from 0–10 mins, and the second phase,
from 10–60 mins, was then calculated for each animal.
Induction of Neuropathic pain
Neuropathic pain was induced according to the Chung
Model (ligation of spinal nerve L5). Baseline mechanical
thresholds for one paw were measured from mice using
von Frey hairs (using the up-down method) respectively.
Animals were anaesthetised using Halothane. A midline
incision was made in the skin of the back at the L2-S2 levels
and the left paraspinal muscles separated from the spinal
processes, facet joints and transverse processes at the L4-S1
Ectopic discharges is unchanged in Nav1.3 KO mouseFigure 4
Ectopic discharges is unchanged in Nav1.3 KO mouse. Ectopic discharges in L5 (cut) and L4 (spared) sensory neurons 
following nerve injury are not different in the Nav1.3 KO global mouse (black). (A) An example trace from spontaneously 
active L5 fibres from Nav1.3 KO mouse. (B) Number of spontaneously active fibres in L5 is 3 times greater than that in L4 (L5 
vs. L4 in WT P = 0.016 and in KO P = 0.016). Spontaneous activity is not different between KO and WT (P = 0.89 in L5 and P 
= 0.98 in L4, n = 6 mice in all groups). (C) Mean number of burst per minute in L5 is double that in L4 (L5 vs. L4 in WT P = 
0.025 and in KO P = 0.022) but not different between KO and WT (P = 0.37 in L5 and P = 0.33 in L4). (D) Mean number of 
spikes per burst is not different between KO and WT (P = 0.58 in L5 and P = 0.61 in L4) and between L5 and L4 (WT P = 0.95 
and in KO P = 0.58). (E) Mean burst length is not different between KO and WT (P = 0.63 in L5 and P = 0.96 in L4) and 
between L5 and L4 (WT P = 0.73 and in KO P = 0.56).
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Neuropathic pain behaviour is unaffected in global and conditional Nav1.3 KO miceFig re 5
Neuropathic pain behaviour is unaffected in global and conditional Nav1.3 KO mice. Robust mechanical allodynia 
developed in both global (A), nociceptor-specific (B) and postnatal KO (C) of Nav1.3 but not in sham operated WT (white tri-
angle in A). The histogram to the left shows the baseline before injury. Nociceptor-specific deletion of Nav1.3 was confirmed 
by PCR on genomic DNA (in B) which shows a product for the floxed Nav1.3 allele in both DRGs and brain. However, only 
DRGs produce the KO allele. Note that non-neuronal cells in DRG will contribute to the floxed Nav1.3 band. In C Co-staining 
in sections from adult DRG from NFH-Cre/Rosa26 mouse shows that most sensory neurons express Cre in NFH-Cre mouse.
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levels. The L5 transverse process was removed and the L5
spinal nerve tightly ligated using 8-0 silk thread.
PCR on Genomic DNA
DNA was precipitated from DRG and brain after over-
night incubation in lysis-buffer (100 mM Tric-Cl, 5 mM
EDTA, 0.2% SDS, 200 mM NaCl and 0.1 mg/ml Protein-
ase K). DNA pellet was resuspended in 200 μl TE and 1 μl
was used for each 25 μl PCR reaction. Nav1.3 Primers
used are (GAGAGAAAGACACTTAAATGCAGACATC),
(GCTTTTTGTTCAAGTCTATCATATTCAAAG) and (AAG
GAT GGC ATC ACC CAC AAG).
RT-PCR
Deletion of exons 4 and 5 was confirmed by reverse tran-
scription PCR (RT-PCR). RNA isolation was performed
using TRIzol Reagent (Invitrogen, Paisley, UK), according
to manufacturer's protocol. The reverse transcription reac-
tion was also performed according to an Invitrogen proto-
col, using random primers. Primers used were
(CACTAAACCCCGTTAGGAAAATTGCT) and (TCCAAGT-
GCTCCCTCTGTCTCCTC). The same primers were used
for sequencing the RT-PCR bands.
Immunohistochemistry
Animals were terminally anaesthetised with 150 mg/kg
sodium pentobarbitone (Rhône Mérieux), and then int-
racardially perfused with ice cold PBS (0.14 M NaCl, 2.7
mM KCl, 10 mM Na2HPO4, 1.7 mMKH2PO4) followed by
ice cold 4% paraformaldehyde/PBS. The tissues were
removed and placed in O.C.T compound. 10 μm sections
were prepared and mounted on Superfrost Plus slides
(BDH). Sections were fixed in 4% paraformaldehyde for 5
mins and washed 3 × 10 mins in PBS + 0.1% Triton-X.
They were blocked and permeabilised in 10% goat serum
(GibcoBRL)/PBS + 0.1% Triton-X for at least 3 hrs at room
temperature. Sections were then incubated in the follow-
ing antisera in 10% goat serum/PBS + 0.3% Triton-X over-
night at 4°C: rabbit anti-beta-galactosidase (5'-3')
(1:500), mouse anti-peripherin (Chemicon) (1:1000) or
mouse anti-neurofilament (Sigma N-52) (1:1000). They
were then washed 3 × 10 mins in PBS + 0.1% Triton-X.
The primary antisera were localised by immunofluores-
cence with Alexa Fluor 594 (Molecular Probes) (1:1000)
and Alexa Fluor 488 (Molecular Probes) (1:1000). The
slides were finally washed 3 × 30 mins at 4°C and
mounted using Aqueous Mounting Solution (Sigma).
Measuring Peak sodium current
Cultures of dorsal root ganglion (DRG) neurons were pre-
pared from adult Nav1.3 null and WT littermate mice. The
animals were killed by cervical dislocation, and dorsal
root ganglia (DRG) were removed and enzymatically dis-
sociated (Dispase/collagenase; Sigma, Poole, Dorset, UK).
The isolated and pooled DRG neurons were plated onto
poly-L-lysine coated glass coverslips and maintained in
culture for 1–2 days.
Electrophysiology and solutions
Conventional voltage-clamp recordings in the whole-cell
patch-clamp configuration were made from neurones of
varying sizes (corresponding to small and medium sized
neurons with a maximum apparent diameter of 43 μm)
using an Axopatch 200B amplifier (Axon Instruments,
Union City, California, USA) driven from a PC generating
pulse protocols (Pclamp 9, Axon Instruments). The neu-
ronal capacitance was estimated through the procedure of
capacity transient cancellation, soon after attaining the
whole-cell configuration. Electrodes were made from
thin-walled glass (Harvard Apparatus, Edenbridge, Kent,
UK) and had an initial resistance of between 1.5 and 2
MΩ when filled with intracellular solution. Series-resist-
ance compensation was set near 70% with a nominal
feed-back lag of 12 ms. Recordings were filtered at 5 KHz
(4-pole Bessel filter) and sampled at 10 KHz. Recordings
were made at room temperature.
TTX-s and TTX-r Na+ currents were recorded in relative iso-
lation by including pharmacological blockers of both K+
and Ca2+ currents in both extracellular and intracellular
media. In order to distinguish TTX-s and TTX-r currents,
recordings were made before and after the addition of 250
nM TTX to the extracellular solution, where the TTX-s
component was subsequently derived by off-line analysis
using digital subtraction. The extracellular solution con-
tained (in mM): NaCl 43.3, Tetraethylammonium Chlo-
ride 96.7, HEPES 10, CaCl2 2.1, MgCl2 2.12, 4-
Aminopyridine 0.5, CsCl 10, KCl 7.5, CdCl2 0.1. The
intracellular solution contained (in mM): CsCl 130, CsF
13, EGTA (Na) 3, Tetraethylammonium Chloride 10,
HEPES 10, CaCl2 1.21, ATP(Mg) 3 mM, GTP (Li) 500 μM.
External and internal solutions were buffered to pH 7.2–
7.3 with the addition of CsOH. Tetrodotoxin (TTX, 250
nM) was locally applied and removed by gravity fed
superfusion. The reagents, with the exception of TTX, were
obtained from Sigma-Aldrich (Poole, Dorset, UK). TTX
was purchased from Alomone Labs (TCS Biologicals,
Botolph Claydon, Bucks, UK).
In order to derive current density measurements, peak Na+
currents were recorded in response to a family of incre-
menting, depolarizing clamp-steps, filtered at 5 KHz (4-
pole Bessel filter) and normally sampled at 20 KHz. The
holding potential was -80 mV, and the clamp-steps were
preceded by a 20 ms pre-pulse. These values of membrane
potential, coupled with the presence of internal F-, were
not optimal for recording TTX-r persistent Na+ current,
and the TTX-r currents analysed always exhibited the volt-
age-dependent and kinetic characteristics of Nav1.8. Cur-
rent density estimates were found by dividing the peak-
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current values by the value estimated for membrane
capacitance. TTX-s current amplitudes were found by off-
line digital subtraction.
Recording of spontaneously active fibres
At defined time points after L5 spinal nerve ligation mice
were anaesthetised via a brief induction with isofluorane
gas followed by an i.p. injection of pentobarbitone (100
mg/kg). A lumbar laminectomy was performed and the L4
and L5 dorsal roots were identified and cut close to the
spinal cord. Both the ventral roots and the L4 spinal nerve
were cut as far distally as possible and then the dorsal
roots, ventral roots, DRGs and spinal nerves (in continu-
ity) from L4 and L5 were carefully and quickly removed.
Throughout the process of dissection the tissue was kept
hydrated by regularly applying oxygenated (95% O2, 5%
CO2) aCSF solution (in millimolar: NaCl 118; KCl 4.7;
MgSO4 1.2; KH2PO4 1.2; NaHCO3 25; CaCl 2.5 and glu-
cose 11) to the preparation. The tissue was then kept in
oxygenated aCSF at room temperature for 30 minutes
before the start of electrophysiological recording. The
peripheral nerve preparations were mounted in a two
chamber recording bath with the spinal nerve and DRG
on one side continuously perfused with oxygenated aCSF
at a rate of 10 ml/min. This solution was kept at 35 ± 1°C
by running the perfusion tube through a jacket containing
water heated and circulated by a thermostatically control-
led water bath. The dorsal and ventral roots were sealed in
the other chamber and covered in mineral oil which had
been previously oxygenated with an air tube. Oil in this
chamber was periodically replaced to maintain hydration
and oxygenation of the dorsal root. A leak-proof partition
barrier of perspex and high-vacuum grease ensured electri-
cal isolation from the other compartment. For the pur-
poses of electrical stimulation the end of the spinal nerve
was taken up into a suction electrode with bipolar silver/
silver chloride wires. Fine filaments were teased from the
dorsal root using sharpened watchmakers forceps. These
strands were placed over electrodes made of sliver wire
coated with teflon that had been stripped away from the
tip. A crushed strand from the ventral root was placed
across another silver wire electrode to act as an indifferent
recording. Signals from the electrodes were passed
through a head-stage which was also connected to earth.
From here the signal was amplified and filtered (low pass
500 Hz, high pass 5 KHz) using Neurolog equipment
(Digitimer, UK). Residual 50 Hz noise was removed with
a Humbug noise eliminator (Quest Scientific, Canada).
The signal was viewed on a digital oscilloscope (Tektro-
nix, USA) and also recorded for off-line analysis (Power-
lab and Chart 5 software, ADI instruments, UK).
Spontaneously active units were recorded in both the L5
and L4 dorsal roots. In strands with multiple ectopically
firing units separation was achieved on the basis of differ-
ing amplitude, action potential shape and interspike
interval. The number of conducting fibres in each strand
was determined by incremental electrical stimulation of
the spinal nerve whilst observing the recruitment of units
on a storage oscilloscope (Gould, UK). Strands that were
studied typically contained a total of 8 to 12 conducting
units and around 50 to 60 units were sampled from each
dorsal root. The proportion of spontaneously active units
in each preparation was calculated as a percentage and
then a mean obtained for all data in a group with n repre-
senting a single L4 or L5 root taken from one animal. A
large proportion of units observed firing spontaneously
did so in a bursting manner and so further analysis of
these patterns was undertaken using specialised software
(Spike 2, Cambridge Electronic Design, UK).
Statistics
Unpaired t-test was used to compare data unless other-
wise indicated.
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